SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SuanFarma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10803
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated tablet, and summum propol, among others. It also provides ironkit, generics services, OTC, baby food, veterinary, plameca, APIs, oncosuan, cidqo, dermotological products; and biotech and development and manufacturing services. SuanFarma Group offers drug development and manufacturing services such as analytical development, stabilities, galenic development, formulation and pilot batches, among others. The company caters to biotechnological, veterinary, pharmaceutical, nutritional and cosmetic sectors. SuanFarma Group is headquartered in Alcobendas, Spain.

SuanFarma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SuanFarma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SuanFarma SA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Intermediate Capital Group Acquires SuanFarma from ProA Capital 10
Equity Offering 11
Idifarma Desarrollo Farmaceutico Secures Investment from Suanfarma 11
Acquisition 12
Lusosuan Acquires 4.76% Stake in CIPAN 12
Suanfarma Acquires CIPAN 13
SuanFarma SA – Key Competitors 14
SuanFarma SA – Key Employees 15
SuanFarma SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SuanFarma SA, Pharmaceuticals & Healthcare, Key Facts 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Deals By Therapy Area, 2012 to YTD 2018 8
SuanFarma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intermediate Capital Group Acquires SuanFarma from ProA Capital 10
Idifarma Desarrollo Farmaceutico Secures Investment from Suanfarma 11
Lusosuan Acquires 4.76% Stake in CIPAN 12
Suanfarma Acquires CIPAN 13
SuanFarma SA, Key Competitors 14
SuanFarma SA, Key Employees 15
SuanFarma SA, Other Locations 16
SuanFarma SA, Subsidiaries 16

List of Figures
SuanFarma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • NeuStar Inc:企業の戦略的SWOT分析
    NeuStar Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Eriks NV:企業の戦略・SWOT・財務情報
    Eriks NV - Strategy, SWOT and Corporate Finance Report Summary Eriks NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • DPL Inc. (DPL):電力:M&Aディール及び事業提携情報
    Summary DPL Inc. (DPL) a subsidiary of AES Corporation is a diversified energy and utility company. It is engaged in the generation, transmission and distribution of electricity in West Central Ohio. The company provides its services to residential, commercial, and industrial and government customer …
  • Lion Corporation:企業の戦略・SWOT・財務情報
    Lion Corporation - Strategy, SWOT and Corporate Finance Report Summary Lion Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Trammo Inc:企業の戦略的SWOT分析
    Trammo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Terme Dobrna D.D.
    Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Omron Healthcare Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Almaty International Airport JSC:企業の戦略・SWOT・財務分析
    Almaty International Airport JSC - Strategy, SWOT and Corporate Finance Report Summary Almaty International Airport JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • MolMed SpA (MLM):製薬・医療:M&Aディール及び事業提携情報
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Lucasfilm Ltd:企業の戦略的SWOT分析
    Lucasfilm Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • International Stem Cell Corp (ISCO):企業の財務・戦略的SWOT分析
    Summary International Stem Cell Corp (ISCC) is a clinical stage biotechnology company that develops stem cell technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of regenerative medicine. It provides stem cells such as embryonic stem cells, adul …
  • Eguana Technologies Inc (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tanabe Research Laboratories USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tanabe Research Laboratories USA Inc (Tanabe Research Laboratories USA), a subsidiary of Mitsubishi Tanabe Pharma Corp is a healthcare research center that discovers and develops biological drugs. The laboratory conducts research on metabolics, immunology and inflammation. Its products are u …
  • Wilbur-Ellis Holdings Inc:企業の戦略的SWOT分析
    Wilbur-Ellis Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ReproCELL Inc (4978):企業の財務・戦略的SWOT分析
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • Rentech Inc (RTKH):企業の財務・戦略的SWOT分析
    Rentech Inc (RTKH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆